These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 31687957)

  • 1. [PHENOTYPIC POLYMORPHISM OF N-ACETYLTRANSFERASE 2 IN PATIENTS WITH DIABETES MELLITUS].
    Doroshkevych I; Yakovleva O; Kyrychenko O; Zhamba A; Pivtorak K
    Georgian Med News; 2019 Sep; (294):91-97. PubMed ID: 31687957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-acetyltransferase 2 acetylation polymorphism: prevalence of slow acetylators does not differ between atopic dermatitis patients and healthy subjects.
    Brocvielle H; Muret P; Goydadin AC; Boone P; Broly F; Kantelip JP; Humbert P
    Skin Pharmacol Appl Skin Physiol; 2003; 16(6):386-92. PubMed ID: 14528063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-acetyltransferase-2 genotypes among Jordanian patients with diabetes mellitus.
    Irshaid YM; Abujbara MA; Ajlouni KM; El-Khateeb M; Jarrar YB
    Int J Clin Pharmacol Ther; 2013 Jul; 51(7):593-9. PubMed ID: 23587153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The N-acetyltransferase (NAT) gene: an early risk marker for diabetic nephropathy in Japanese type 2 diabetic patients?
    Neugebauer S; Baba T; Watanabe T; Ishizaki T; Kurokawa K
    Diabet Med; 1994 Oct; 11(8):783-8. PubMed ID: 7851073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between bone loss in periodontal disease and polymorphism of N-acetyltransferase (NAT2).
    Kocher T; Sawaf H; Fanghänel J; Timm R; Meisel P
    J Clin Periodontol; 2002 Jan; 29(1):21-7. PubMed ID: 11846845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased genotype frequency of N-acetyltransferase 2 slow acetylation in patients with rheumatoid arthritis.
    Pawlik A; Ostanek L; Brzosko I; Gawroska-Szklarz B; Brzosko M; Dabrowska-Zamojcin E
    Clin Pharmacol Ther; 2002 Sep; 72(3):319-25. PubMed ID: 12235453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic analysis of the NAT2 and CYP2D6 polymorphisms in white patients with non-insulin-dependent diabetes mellitus.
    Agúndez JA; Menaya JG; Tejeda R; Lago F; Chávez M; Benítez J
    Pharmacogenetics; 1996 Oct; 6(5):465-72. PubMed ID: 8946479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acetylator status and N-acetyltransferase 2 gene polymorphisms; phenotype-genotype correlation with the sulfamethazine test.
    Taja-Chayeb L; González-Fierro A; Miguez-Muñoz C; Trejo-Becerril C; Cruz-Hernandez Ede L; Cantu D; Agundez JA; Vidal-Millan S; Gutierrez O; Dueñas-González A
    Pharmacogenet Genomics; 2011 Dec; 21(12):894-901. PubMed ID: 21946899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arylamine N-acetyltransferase 2 slow acetylator polymorphisms in unrelated Iranian individuals.
    Bakayev VV; Mohammadi F; Bahadori M; Sheikholslami M; Javeri A; Masjedi MR; Velayati AA
    Eur J Clin Pharmacol; 2004 Sep; 60(7):467-71. PubMed ID: 15316701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-acetyltransferase 2 polymorphism in patients with diabetes mellitus.
    Yalin S; Hatungil R; Tamer L; Ates NA; Dogruer N; Yildirim H; Karakas S; Atik U
    Cell Biochem Funct; 2007; 25(4):407-11. PubMed ID: 16397907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical relevance of N-acetyltransferase type 2 (NAT2) genetic polymorphism].
    Furet Y; Bechtel Y; Le Guellec C; Bechtel PR; Autret-Leca E; Paintaud G
    Therapie; 2002; 57(5):427-31. PubMed ID: 12611196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative analysis of N-acetylation polymorphism in humans as determined by phenotyping and genotyping].
    Goldenkova-Pavlova IV; Bruskin SA; Abdeev RM; Markarova EV; Bigvava SG; Radkevich LA; Kozhekbaeva ZhM; Glotov AS; Gra OA; Zasedatelev AS; Nasedkina TV; Kurdanov KhA; Piruzian ES
    Genetika; 2006 Aug; 42(8):1143-50. PubMed ID: 17025166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cigarette smoking, N-acetyltransferase 2 polymorphisms and systemic lupus erythematosus in a Japanese population.
    Kiyohara C; Washio M; Horiuchi T; Tada Y; Asami T; Ide S; Takahashi H; Kobashi G;
    Lupus; 2009 Jun; 18(7):630-8. PubMed ID: 19433464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphic arylamine N-acetyltransferase (NAT2) genes in children with insulin-dependent diabetes mellitus.
    Mrozikiewicz PM; Drakoulis N; Roots I
    Clin Pharmacol Ther; 1994 Dec; 56(6 Pt 1):626-34. PubMed ID: 7995004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of association between arylamine N-acetyltransferase 2 (NAT2) polymorphism and systemic sclerosis.
    Skretkowicz K; Skretkowicz J; Gawrońska-Szklarz B; Górnik W; Rychlik-Sych M; Sysa-Jedrzejowska A
    Eur J Clin Pharmacol; 2005 Jan; 60(11):773-8. PubMed ID: 15565348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between acetylation phenotype and genotype in Chinese women.
    Zhao B; Seow A; Lee EJ; Lee HP
    Eur J Clin Pharmacol; 2000 Dec; 56(9-10):689-92. PubMed ID: 11214777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glutathione S-transferase and N-acetyltransferase genotypes and asbestos-associated pulmonary disorders.
    Hirvonen A; Saarikoski ST; Linnainmaa K; Koskinen K; Husgafvel-Pursiainen K; Mattson K; Vainio H
    J Natl Cancer Inst; 1996 Dec; 88(24):1853-6. PubMed ID: 8961976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on N-Acetyltransferase (NAT2) Genotype Relationships in Emiratis: Confirmation of the Existence of Phenotype Variation among Slow Acetylators.
    Al-Ahmad MM; Amir N; Dhanasekaran S; John A; Abdulrazzaq YM; Ali BR; Bastaki S
    Ann Hum Genet; 2017 Sep; 81(5):190-196. PubMed ID: 28653770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferases.
    Hein DW; Doll MA; Rustan TD; Gray K; Feng Y; Ferguson RJ; Grant DM
    Carcinogenesis; 1993 Aug; 14(8):1633-8. PubMed ID: 8353847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-acetyltransferase (NAT2) polymorphism and breast cancer susceptibility: a lack of association in a case-control study of Turkish population.
    Kocabaş NA; Sardaş S; Cholerton S; Daly AK; Karakaya AE
    Int J Toxicol; 2004; 23(1):25-31. PubMed ID: 15162844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.